Colorcon Acquires Airnov

Colorcon is a provider of pharmaceutical technologies and a manufacturer of specialty chemicals for related industries. The company's best-of-class technologies are complemented by value-added services, including technical and global regulatory information services, training seminars and independent research support. The primary market for Colorcon is serving manufacturers of pharmaceutical products in the areas of modified release technologies, excipients, and film coatings for solid oral dosage development. These products are used in the prescription and OTC drug, nutritional supplement and veterinary product markets. The specialty chemicals groups at Colorcon provide coatings, polishes, colorants and inks for the food and confectionery markets, and non-toxic printing inks and functional coatings used in direct and indirect contact applications involving food, medical devices and associated packaging.

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.